Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus

[1]  G. Réus,et al.  Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels. , 2008, Basic & clinical pharmacology & toxicology.

[2]  Eric J. Nestler,et al.  The molecular neurobiology of depression , 2008, Nature.

[3]  Hiroshi Morita,et al.  Alkaloids from the seeds of Peganum harmala showing antiplasmodial and vasorelaxant activities , 2008, Journal of Natural Medicines.

[4]  G. Réus,et al.  Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[5]  J. Landeira-Fernández,et al.  Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members. , 2007, Journal of ethnopharmacology.

[6]  Dinara Jaqueline Moura,et al.  Antioxidant properties of beta-carboline alkaloids are related to their antimutagenic and antigenotoxic activities. , 2007, Mutagenesis.

[7]  R. Damoiseaux,et al.  The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARgamma expression. , 2007, Cell metabolism.

[8]  E. Castrén,et al.  Role of neurotrophic factors in depression. , 2007, Current opinion in pharmacology.

[9]  Paul J Carlson,et al.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. , 2006, Archives of general psychiatry.

[10]  D. Farzin,et al.  Antidepressant-like effect of harmane and other β-carbolines in the mouse forced swim test , 2006, European Neuropsychopharmacology.

[11]  R. Mcarthur,et al.  Animal models of depression in drug discovery: A historical perspective , 2006, Pharmacology Biochemistry and Behavior.

[12]  R. Duman,et al.  A Neurotrophic Model for Stress-Related Mood Disorders , 2006, Biological Psychiatry.

[13]  B. Frey,et al.  Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. , 2006, Life sciences.

[14]  Teruo Hayashi,et al.  Chronic Antidepressants Potentiate via Sigma-1 Receptors the Brain-derived Neurotrophic Factor-induced Signaling for Glutamate Release* , 2006, Journal of Biological Chemistry.

[15]  M. O'Neill,et al.  Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment , 2004, Neuroscience.

[16]  M. Barrot,et al.  Essential role of brain-derived neurotrophic factor in adult hippocampal function. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  T. B. Üstün,et al.  Global burden of depressive disorders in the year 2000 , 2004, British Journal of Psychiatry.

[18]  Jian Wang,et al.  Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine. , 2004, Biochemical and biophysical research communications.

[19]  L. Stinus,et al.  In the rat forced swimming test, chronic but not subacute administration of dual 5-HT/NA antidepressant treatments may produce greater effects than selective drugs , 2002, Behavioural Brain Research.

[20]  A. Rush,et al.  The impact of treatment-resistant depression on health care utilization and costs. , 2002, The Journal of clinical psychiatry.

[21]  E. Jutkiewicz,et al.  Nonpeptidic δ-opioid Receptor Agonists Reduce Immobility in the Forced Swim Assay in Rats , 2002, Neuropsychopharmacology.

[22]  R. Duman,et al.  Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression , 2002, The Journal of Neuroscience.

[23]  J. Aubry,et al.  Decreased serum brain-derived neurotrophic factor levels in major depressed patients , 2002, Psychiatry Research.

[24]  P. Skolnick.  Beyond monoamine-based therapies: clues to new approaches. , 2002, The Journal of clinical psychiatry.

[25]  E. Louis,et al.  TOXICOKINETICS OF TREMOROGENIC NATURAL PRODUCTS, HARMANE AND HARMINE, IN MALE SPRAGUE-DAWLEY RATS , 2001, Journal of toxicology and environmental health. Part A.

[26]  D. Nutt,et al.  β-carboline binding to imidazoline receptors , 2001 .

[27]  Chung-Soo Lee,et al.  Protective effect of harmaline and harmalol against dopamine‐ and 6‐hydroxydopamine‐induced oxidative damage of brain mitochondria and synaptosomes, and viability loss of PC12 cells , 2001, The European journal of neuroscience.

[28]  P Pacher,et al.  Current trends in the development of new antidepressants. , 2001, Current medicinal chemistry.

[29]  R. Glennon,et al.  Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors , 2000 .

[30]  T. Sourkes,et al.  "Rational hope" in the early treatment of Parkinson's disease. , 1999, Canadian journal of physiology and pharmacology.

[31]  M. Ferigolo,et al.  Ethopharmacology of imipramine in the forced-swimming test: gender differences , 1998, Neuroscience & Biobehavioral Reviews.

[32]  D. Charney.  Monoamine dysfunction and the pathophysiology and treatment of depression. , 1998, The Journal of clinical psychiatry.

[33]  J. Siuciak,et al.  Antidepressant-Like Effect of Brain-derived Neurotrophic Factor (BDNF) , 1997, Pharmacology Biochemistry and Behavior.

[34]  R. Duman,et al.  Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[35]  J. Siuciak,et al.  BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration , 1996, Brain Research.

[36]  Michael Rickels,et al.  Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants , 1995, Psychopharmacology.

[37]  Z. Górka,et al.  Effects of neuroleptics displaying antidepressant activity on behavior of rats in the forced swimming test , 1985, Pharmacology Biochemistry and Behavior.

[38]  Porsolt Rd.  Animal model of depression. , 1979 .

[39]  R. Kociba,et al.  Induction of pulmonary carcinoma in rats by chronic inhalation of dust from pulverized asbestos pipe covering. , 1978, Journal of toxicology and environmental health.

[40]  R. Porsolt,et al.  Depression: a new animal model sensitive to antidepressant treatments , 1977, Nature.

[41]  R. Takahashi,et al.  An animal model of depression. , 1974, Biological psychiatry.

[42]  D. Bylund,et al.  Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. , 2008, Pharmacology & therapeutics.

[43]  E. Jutkiewicz,et al.  Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats. , 2002, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[44]  R. Glennon,et al.  Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors. , 2000, Drug and alcohol dependence.

[45]  R. Ramsay,et al.  Inhibition of monoamine oxidase A by beta-carboline derivatives. , 1997, Archives of biochemistry and biophysics.

[46]  R. Ramsay,et al.  Inhibition of Monoamine Oxidase A by β-Carboline Derivatives , 1997 .

[47]  Y. Barde,et al.  Physiology of the neurotrophins. , 1996, Annual review of neuroscience.

[48]  H. Aihara,et al.  Effect of chronic administration of antidepressants on duration of immobility in rats forced to swim. , 1986, Japanese journal of pharmacology.

[49]  Global burden of depressive disorders in the year Global burden of depressive disorders in the year , 2022 .